Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.71275 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.69772 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.69883 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.62819 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.58868 | 28 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.74659 | 30 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.22129 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.66659 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67039 | 30 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.68988 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.6812 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.61575 | 28 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.68369 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.97651 | 42 |